SPLV vs XBI
Invesco S&P 500 Low Volatility ETF vs SPDR S&P Biotech ETF
- • SPLV has the lower expense ratio at 0.25% vs 0.35% for XBI.
- • SPLV pays a higher dividend yield (2.14%).
Side-by-side metrics
| Metric | SPLV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.25% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.14% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $7.06B | $10.73B |
YTD return | 7.40% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.37 | 1.10 |
P/E ratio | 21.24 | — |
Last price | $75.68 | $164.01 |
Inception | — | — |
Issuer | Invesco | State Street |
SPLV top holdings
| L | Loews Corp | 1.37% |
| FE | FirstEnergy Corp | 1.33% |
| BRK-B | Berkshire Hathaway Inc Class B | 1.31% |
| LNT | Alliant Energy Corp | 1.27% |
| DTE | DTE Energy Co | 1.26% |
| WEC | WEC Energy Group Inc | 1.26% |
| JNJ | Johnson & Johnson | 1.26% |
| AEE | Ameren Corp | 1.26% |
| DUK | Duke Energy Corp | 1.24% |
| EVRG | Evergy Inc | 1.24% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About SPLV
SPLV (Invesco S&P 500 Low Volatility ETF) is 100 lowest-volatility S&P 500 stocks. Managed by Invesco, the fund carries $7.1B in assets under management, an expense ratio of 0.25%, a dividend yield of 2.14%. Its largest holding is Loews Corp (L), which represents 1.4% of the portfolio. Real Estate is the fund's largest sector exposure at 17.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.